Accumulate Anupam Rasayan India; target of Rs 1230: Deven Choksey

Deven Choksey's research report on Anupam Rasayan India

Consolidated revenue for the quarter increased by 91.1% YoY (-2.9% QoQ) to INR 4,858 Mn., stood sharply above our estimates, led by rapid ramp-up of pharma molecule, strong rebound in agrochemicals, commercialization of polymer products, new global contracts, and higher export revenue mix. Outlook

We have rolled forward our valuation to Jun’27 estimates. We value Anupam Rasayan at 45.0x Jun’27 EPS (near to its 3-year Avg. NTM P/E"), implying a target price of INR 1,230. We reiterate our “ACCUMULATE” rating on the stock.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.